STOCK TITAN

CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Very Positive)
Tags
CBD Life Sciences Inc. (CBDL) reported an extraordinary 1,502.30% revenue increase from January through May 2025, reflecting an annualized growth rate over 4,000%. The company has successfully transformed from a CBD-focused business to a diversified wellness brand, expanding across multiple retail channels including Walmart Marketplace, DoorDash, Leafly, and Groupon. CBDL's growth is driven by product innovation in functional wellness, including mushroom smoothies, brain support blends, and adaptogenic supplements. The company has established presence in both digital and physical platforms, with popular products like 3000MG Pain Relief Cream and male vitality supplements. Under CEO Lisa Nelson's leadership, CBDL is capitalizing on the expanding CBD and mushroom supplement markets, projected to reach $30 billion and $15 billion respectively by 2028.
CBD Life Sciences Inc. (CBDL) ha registrato un aumento straordinario dei ricavi del 1.502,30% da gennaio a maggio 2025, con un tasso di crescita annualizzato superiore al 4.000%. L'azienda si è trasformata con successo da un'attività focalizzata esclusivamente sul CBD a un marchio di benessere diversificato, espandendosi in diversi canali di vendita al dettaglio, tra cui Walmart Marketplace, DoorDash, Leafly e Groupon. La crescita di CBDL è guidata dall'innovazione di prodotto nel settore del benessere funzionale, con prodotti come frullati ai funghi, miscele per il supporto cerebrale e integratori adattogeni. L'azienda ha consolidato la sua presenza sia sulle piattaforme digitali sia su quelle fisiche, con prodotti popolari come la crema antidolorifica da 3000MG e integratori per la vitalità maschile. Sotto la guida della CEO Lisa Nelson, CBDL sta sfruttando la crescita dei mercati del CBD e degli integratori a base di funghi, che si prevede raggiungeranno rispettivamente 30 miliardi e 15 miliardi di dollari entro il 2028.
CBD Life Sciences Inc. (CBDL) reportó un aumento extraordinario en ingresos del 1.502,30% desde enero hasta mayo de 2025, reflejando una tasa de crecimiento anualizada superior al 4.000%. La compañía se ha transformado exitosamente de un negocio centrado en CBD a una marca diversificada de bienestar, expandiéndose a múltiples canales minoristas como Walmart Marketplace, DoorDash, Leafly y Groupon. El crecimiento de CBDL está impulsado por la innovación en productos de bienestar funcional, incluyendo batidos de hongos, mezclas para el apoyo cerebral y suplementos adaptogénicos. La empresa ha establecido presencia tanto en plataformas digitales como físicas, con productos populares como la crema para alivio del dolor de 3000MG y suplementos para la vitalidad masculina. Bajo el liderazgo de la CEO Lisa Nelson, CBDL está capitalizando los crecientes mercados de suplementos de CBD y hongos, que se proyecta alcanzarán los 30 mil millones y 15 mil millones de dólares respectivamente para 2028.
CBD Life Sciences Inc.(CBDL)는 2025년 1월부터 5월까지 매출이 1,502.30% 급증하며 연 환산 성장률이 4,000%를 넘는 놀라운 성과를 보고했습니다. 이 회사는 CBD 중심 사업에서 벗어나 다양한 웰니스 브랜드로 성공적으로 전환했으며, Walmart Marketplace, DoorDash, Leafly, Groupon 등 여러 소매 채널로 확장했습니다. CBDL의 성장은 기능성 웰니스 제품 혁신에 힘입어 버섯 스무디, 두뇌 지원 블렌드, 아답토젠 보충제 등이 포함됩니다. 디지털과 오프라인 플랫폼 모두에서 입지를 구축했으며, 3000MG 통증 완화 크림과 남성 활력 보충제 같은 인기 제품을 보유하고 있습니다. CEO 리사 넬슨의 리더십 아래 CBDL은 2028년까지 각각 300억 달러와 150억 달러에 이를 것으로 예상되는 CBD 및 버섯 보충제 시장의 성장 기회를 적극 활용하고 있습니다.
CBD Life Sciences Inc. (CBDL) a enregistré une augmentation extraordinaire de ses revenus de 1 502,30 % entre janvier et mai 2025, reflétant un taux de croissance annualisé de plus de 4 000 %. L'entreprise s'est transformée avec succès, passant d'une activité centrée sur le CBD à une marque de bien-être diversifiée, s'étendant à plusieurs canaux de distribution, notamment Walmart Marketplace, DoorDash, Leafly et Groupon. La croissance de CBDL est portée par l'innovation produit dans le bien-être fonctionnel, incluant des smoothies aux champignons, des mélanges pour le soutien cérébral et des compléments adaptogènes. L'entreprise s'est implantée sur des plateformes digitales et physiques, avec des produits populaires tels que la crème analgésique 3000MG et des compléments pour la vitalité masculine. Sous la direction de la PDG Lisa Nelson, CBDL exploite les marchés en expansion des compléments à base de CBD et de champignons, qui devraient atteindre respectivement 30 milliards et 15 milliards de dollars d'ici 2028.
CBD Life Sciences Inc. (CBDL) verzeichnete von Januar bis Mai 2025 einen außergewöhnlichen Umsatzanstieg von 1.502,30 %, was einer annualisierten Wachstumsrate von über 4.000 % entspricht. Das Unternehmen hat sich erfolgreich von einem auf CBD fokussierten Geschäft zu einer diversifizierten Wellness-Marke entwickelt und ist in mehreren Einzelhandelskanälen wie Walmart Marketplace, DoorDash, Leafly und Groupon vertreten. Das Wachstum von CBDL wird durch Produktinnovationen im Bereich funktionelles Wohlbefinden vorangetrieben, darunter Pilz-Smoothies, Gehirnunterstützungs-Mischungen und adaptogene Nahrungsergänzungsmittel. Das Unternehmen ist sowohl auf digitalen als auch physischen Plattformen präsent und bietet beliebte Produkte wie die 3000MG Schmerzcreme und Vitalitätspräparate für Männer an. Unter der Führung von CEO Lisa Nelson nutzt CBDL die wachsenden Märkte für CBD- und Pilzpräparate, die bis 2028 voraussichtlich jeweils 30 Milliarden bzw. 15 Milliarden US-Dollar erreichen werden.
Positive
  • Exceptional revenue growth of 1,502.30% from January to May 2025
  • Successful expansion into major retail platforms including Walmart Marketplace
  • Diversification beyond CBD into high-growth mushroom and adaptogenic supplement markets
  • Strong product innovation with multiple new SKUs across wellness categories
  • Strategic presence across multiple sales channels (retail, digital, direct-to-consumer)
Negative
  • Heavy reliance on U.S. market with limited international presence
  • Potential challenges in maintaining such high growth rates long-term
  • Intense competition in rapidly growing wellness and CBD markets

Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion.

SCOTTSDALE, AZ / ACCESS Newswire / June 11, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising player in the natural health and wellness space, is proud to report a 1,502.30% increase in revenue from January through May of 2025 - a historic milestone for the company and a clear reflection of its expanding presence across retail, digital, and direct-to-consumer channels.

This performance marks the company's strongest run of sustained month-over-month revenue growth to date and comes as CBDL shifts from a single-category CBD company to a diversified wellness brand with products designed for modern performance, recovery, and cognitive support.

"This isn't just about selling more products - it's about becoming a health brand that consumers actively seek out," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We've laid the foundation for scalable, repeatable success by combining innovation, access, and a strong identity in functional wellness."

Key Drivers Of Growth

National Retail Expansion & E-Commerce Ubiquity
CBDL's ability to meet consumers where they shop has been a major growth catalyst in 2025. The brand has successfully launched and scaled across high-traffic digital and physical platforms, including:

  • Walmart Marketplace: Multiple SKUs now available online, including CBDL's best-selling 3000MG Pain Relief Cream and skin care formulations.

  • DoorDash & Leafly: Products are accessible via local delivery in select markets, offering speed and convenience for customers.

  • Groupon: Strategic limited-time wellness deals driving strong first-time purchase activity and consumer discovery.

  • Shopify & Reddit: Expanded direct-to-consumer operations through Shopify, complemented by engagement in Reddit's niche wellness communities to boost brand awareness and customer acquisition.

Product Innovation: Functional Wellness for the Modern Consumer

CBDL's revenue growth closely aligns with its rapid innovation across plant-powered health categories. Beyond CBD, the company is gaining traction with functional and adaptogenic wellness products, including:

  • Mushroom Smoothies & Brain Support Blends: Featuring natural cognitive enhancers like lion's mane, reishi, and cordyceps, these smoothies support memory, mental clarity, and energy - and are appearing in local coffee shops and health stores.

  • Power+ Sexual Enhancement Supplement: A plant-based formula supporting male vitality, stamina, and circulation, quickly becoming a customer favorite.

  • Adaptogenic Mushroom Supplements: Proprietary blends designed to support immune health, stress reduction, and overall daily balance, harnessing reishi, chaga, lion's mane, and ashwagandha.

Strategic Vision & Responsible Growth

CBDL continues to invest in infrastructure, brand visibility, and strategic partnerships to ensure long-term sustainable growth. While focusing on the U.S. market currently, the company is evaluating future expansion opportunities and additional retail collaborations.

"Our focus remains on delivering real value through trusted products and accessible retail channels," added Nelson. "We are committed to building a wellness brand that serves consumers authentically while creating shareholder value."

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. is an Arizona-based health and wellness company focused on premium CBD, adaptogenic, and mushroom-based wellness products designed to support modern lifestyles. From pain relief to cognitive support and men's health, CBDL is committed to transparency, innovation, and accessibility.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.



View the original press release on ACCESS Newswire

FAQ

What was CBDL's revenue growth percentage from January to May 2025?

CBD Life Sciences Inc. reported a 1,502.30% revenue increase from January through May 2025, equivalent to an annualized growth rate exceeding 4,000%.

Which major retail platforms now carry CBDL products?

CBDL products are available on Walmart Marketplace, DoorDash, Leafly, Groupon, Shopify, and Reddit platforms.

What new product categories has CBDL expanded into beyond CBD?

CBDL has expanded into mushroom smoothies, brain support blends, Power+ Sexual Enhancement Supplement, and adaptogenic mushroom supplements featuring ingredients like lion's mane, reishi, and cordyceps.

What is the market size projection for CBD and mushroom supplements by 2028?

The CBD market is projected to reach $30 billion and the mushroom supplement market is expected to reach $15 billion by 2028.

Who is the current CEO of CBD Life Sciences Inc.?

Lisa Nelson serves as the President & CEO of CBD Life Sciences Inc.
Cbd Life Science

OTC:CBDL

CBDL Rankings

CBDL Latest News

CBDL Stock Data

1.11M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Scottsdale